The way accountable care organizations are set up makes them a perfect system of care for high-need, high-cost patients who might otherwise fall through the cracks of traditional delivery models, said Rob Mechanic, MBA, senior fellow at the Heller School of Social Policy and Management at Brandeis University and executive director of the Institute for Accountable Care.
The way accountable care organizations are set up makes them a perfect system of care for high-need, high-cost patients who might otherwise fall through the cracks of traditional delivery models, said Rob Mechanic, MBA, senior fellow at the Heller School of Social Policy and Management at Brandeis University and executive director of the Institute for Accountable Care.
Transcript
What is the role accountable care organizations can play in caring for high-need, high-cost patients?
First of all, the system is really failing high-need, high-costs patients. So, these are people who have complex illness, they’re frail, they’re socially isolated, they may have a lot of social factors that are affecting their health and their life, and they fall through the cracks of the traditional systems.
Now the ACOs, you really need a system of care to do the best that you can for these patients. They’re very expensive they are not only high utilizers but high utilizers of care that is avoidable care—a lot of unnecessary care—and so the ACO is our system of care. So, they’re well suited to try and fill those gaps.
The other issue is that a lot of the things that this population needs are not covered under traditional payment models or they’re under reimbursed. So, a home visit—physician visits at home, nurse visits at home—that don’t fit into the typical Medicare home healthcare visit. Other kinds of social supports—getting people appropriate food or helping them with housing. Those are things that aren’t paid for but in a global budget model, as in an ACO, there’s really more opportunity to be creative and do the right things for the patient and not just the things that Medicare will pay for. So, I think ACOs are very well positioned to help this group and it’s a real need in our system.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More